EUVIMEDEUVIMED entdecken
Kohortenstudie

Tumor necrosis alpha inhibitor therapy is associated with increased long-term risk of non-melanoma skin cancer and melanoma: a retrospective cohort study

Conor B Driscoll, Gabrielle Schwab, Victor L Quan, Jenna McKenney, Madeline J Hooper, Sai Kaushik Shankar Ramesh Kumar, Roopal V Kundu, Shilajit D Kundu

Journal of the American Academy of Dermatology · 2026

DOI: 10.1016/j.jaad.2026.02.035 ↗

Kurz gefasst

Kohortenstudie in der Zeitschrift Journal of the American Academy of Dermatology, 2026. Verfasst von Conor B Driscoll und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, Illinois. Electronic address: conor.driscoll@northwestern.edu. Hauptthemen laut MEDLINE: Skin Neoplasms, Tumor Necrosis Factor-alpha, Melanoma, Basal Cell Carcinoma.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

BACKGROUND: TNF-α inhibitors (TNF-I) are widely used to treat chronic inflammatory diseases, although there may be an associated risk of nonmelanoma skin cancer (NMSC) and melanoma. OBJECTIVE: To evaluate if TNF-I exposure is associated with an increased risk or severity of NMSC or melanoma. METHODS: A retrospective cohort study of adults with chronic inflammatory disease from 1996 to 2020. Primary outcome was basal cell carcinoma, squamous cell carcinoma, or melanoma diagnosis. Skin cancer diagnosis identified via International Classification of Diseases code and TNF-I exposure were manually reviewed for accuracy. Differential malignancy risk was analyzed by multivariable Cox proportional hazards to determine adjusted hazard ratios with disease severity stratification. RESULTS: Of 56,209 patients with chronic inflammatory conditions, 13,377 had TNF-I exposure. TNF-I exposure was significantly associated with increased risk of any cutaneous malignancy, melanoma, squamous cell carcinoma, and basal cell carcinoma. No significant differences in NMSC histopathological severity or melanoma clinical stage were found between TNF-I exposed and unexposed patients. LIMITATIONS: Retrospective design, variability in patient-level risk factor documentation. CONCLUSION: TNF-I therapy in patients with inflammatory disease is associated with increased risk of NMSC and melanoma diagnosis but not severity. Prescribers of TNF-I should be aware of this increased risk, which may impact skin cancer screening patterns.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Skin NeoplasmsTumor Necrosis Factor-alphaMelanomaBasal Cell CarcinomaCarcinoma, Squamous CellHumansRetrospective StudiesFemaleMaleMiddle AgedAgedAdultNon-Melanoma Skin NeoplasmsCutaneous Squamous Cell CarcinomaRisk FactorsRisk AssessmentSeverity of Illness Index

Stichwörter der Autor:innen

NMSCTNF-alphabasal cell carcinomaimmunosuppressionmelanomaretrospective cohortsquamous cell carcinomatumor necrosis factor alpha

Substanzen

Tumor Necrosis Factor-alpha

Autor:innen und Institutionen

  • Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, Illinois. Electronic address: conor.driscoll@northwestern.edu.
  • Department of Dermatology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
  • Department of Urology, Northwestern University Feinberg School of Medicine, Chicago, Illinois.

Zitieren

APA

Driscoll, C. B., Schwab, G., Quan, V. L., McKenney, J., Hooper, M. J., Ramesh Kumar, S. K. S., Kundu, R. V., & Kundu, S. D. (2026). Tumor necrosis alpha inhibitor therapy is associated with increased long-term risk of non-melanoma skin cancer and melanoma: a retrospective cohort study. Journal of the American Academy of Dermatology. https://doi.org/10.1016/j.jaad.2026.02.035

Vancouver

Driscoll CB, Schwab G, Quan VL, McKenney J, Hooper MJ, Ramesh Kumar SKS, et al. Tumor necrosis alpha inhibitor therapy is associated with increased long-term risk of non-melanoma skin cancer and melanoma: a retrospective cohort study. Journal of the American Academy of Dermatology. 2026. doi:10.1016/j.jaad.2026.02.035

BibTeX
@article{Driscoll2026,
  author = {Driscoll, Conor B and Schwab, Gabrielle and Quan, Victor L and McKenney, Jenna and Hooper, Madeline J and Ramesh Kumar, Sai Kaushik Shankar and Kundu, Roopal V and Kundu, Shilajit D},
  title = {Tumor necrosis alpha inhibitor therapy is associated with increased long-term risk of non-melanoma skin cancer and melanoma: a retrospective cohort study},
  journal = {Journal of the American Academy of Dermatology},
  year = {2026},
  doi = {10.1016/j.jaad.2026.02.035}
}
Kostenlos starten →